Improved Care for Pulmonary Embolism

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Michigan

No Placebo Group

Trial Summary

What is the purpose of this trial?

This study is a quality improvement project to evaluate health care management of pulmonary embolism (PE) patients. The researchers are testing an intervention to determine if it prevents unnecessary hospital admissions.

Eligibility Criteria

This trial is for individuals who arrive at the emergency department with a pulmonary embolism (PE), which is a blockage in one of the lung's arteries. The study aims to include those who might benefit from improved care processes.

Inclusion Criteria

Participation in MEDIC collaborative

Identified site physician champion

Annual volume of acute PE ≥80 (measured in 2022)

Exclusion Criteria

No site physician champion identified

I am following a specific outpatient plan for managing my low-risk pulmonary embolism.

Annual volume of acute PE <80 (measured in 2022)

Participant Groups

The intervention being tested involves new procedures for managing PE patients in the emergency department, with a focus on reducing unnecessary hospital admissions while maintaining patient safety and quality of care.

Group I: MEDIC site Experimental Treatment 1 Intervention

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Michigan Emergency Department Improvement Collaborative partners Ann Arbor, MI

Who Is Running the Clinical Trial?

University of Michigan Lead Sponsor

National Heart, Lung, and Blood Institute (NHLBI) Collaborator

References